Neshima ^{For Profit}

Neshima Medical is a preclinical stage therapeutic company that aims to reduce mortality rates and hospitalization days by utilizing its patented liquid-foam therapy (LiFT™) for respiratory drug delivery. The company's vision is to treat severe pneumonia and asthma using existing small molecules, COPD using topical cell therapy, IPF using slow-release particles, CF using gene therapy, and more. LiFT™ enables for the first-time topical and fast administration of high doses of therapeutics throughout the lungs, and through constricted and mucus obstructed airways, including cells and large size particles. The company's contact information is available on the website.